Alpha Tau Announces Results of First US Clinical Trial of Alpha DaRT™ in Malignant Skin & Soft Tissue Cancers, Showing Complete Response in All Ten Treated Tumors at Approximately 12 Weeks and N
Go back to Alpha Tau Announces Results of First US Clinical Trial of Alpha DaRT™ in Malignant Skin & Soft Tissue Cancers, Showing Complete Response in All Ten Treated Tumors at Approximately 12 Weeks and N| (NASDAQ: HCCC) | Delayed: 12.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.74 | 52 Week High | $ | |||
| Open | $12.20 | 52 Week Low | $ | |||
| Day High | $12.74 | P/E | N/A | |||
| Day Low | $12.74 | EPS | $ | |||
| Volume | 554,022 | |||||
| (NASDAQ: HCCCU) | Delayed: 12.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.88 | 52 Week High | $ | |||
| Open | $11.99 | 52 Week Low | $ | |||
| Day High | $12.88 | P/E | N/A | |||
| Day Low | $12.88 | EPS | $ | |||
| Volume | 614,944 | |||||
